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Abstract
Background: Case-	finding	for	dementia	is	practised	by	general	practitioners	(GPs)	in	
Australia	but	without	an	awareness	of	community	preferences.	We	explored	the	val-
ues	and	preferences	of	 informed	community	members	around	case-	finding	for	de-
mentia	in	Australian	general	practice.
Design, setting and participants: A	before	and	after,	mixed-	methods	study	in	Gold	
Coast,	Australia,	with	ten	community	members	aged	50-	70.
Intervention: A	2-	day	citizen/community	jury.	Participants	were	informed	by	experts	about	
dementia,	the	potential	harms	and	benefits	of	case-	finding,	and	ethical	considerations.
Primary and secondary outcomes: We	asked	participants,	“Should	the	health	system	
encourage	GPs	to	practice	‘case-	finding’	of	dementia	in	people	older	than	50?”	Case-	
finding	was	defined	as	a	GP	initiating	testing	for	dementia	when	the	patient	is	una-
ware	 of	 symptoms.	 We	 also	 assessed	 changes	 in	 participant	 comprehension/
knowledge,	attitudes	towards	dementia	and	participants’	own	intentions	to	undergo	
case-	finding	for	dementia	if	it	were	suggested.
Results: Participants	voted	unanimously	against	case-	finding	for	dementia,	citing	a	lack	
of	effective	treatments,	potential	 for	harm	to	patients	and	potential	 financial	 incen-
tives.	However,	they	recognized	that	case-	finding	was	currently	practised	by	Australian	
GPs	and	recommended	specific	changes	to	the	guidelines.	Participants	increased	their	
comprehension/knowledge	of	dementia,	their	attitude	towards	case-	finding	became	
less	positive,	and	their	intentions	to	be	tested	themselves	decreased.
Conclusion: Once	informed,	community	jury	participants	did	not	agree	case-	finding	
for	dementia	should	be	conducted	by	GPs.	Yet	their	personal	 intentions	to	accept	
case-	finding	varied.	If	case-	finding	for	dementia	is	recommended	in	the	guidelines,	
then	shared	decision	making	is	essential.
K E Y WO RD S
citizen	jury,	community	jury,	dementia,	general	practice,	primary	care,	public	health
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1  | INTRODUCTION
Early	diagnosis	of	dementia	 is	a	challenging	 issue	 for	primary	care	
physicians,	largely	due	to	concerns	arising	from	the	fragile	balance	of	
harms	and	benefits,1-3	the	imprecision	of	some	assessment	tools4,5 
psychological	distress,	reduced	quality	of	life6	and	financial	burden.3 
Multiple	countries	including	Australia,	the	UK,	the	USA	and	Canada	
have	guidelines	that	consider	“early	identification”	of	dementia	but	
these	countries	do	not	support	screening	for	dementia.5,7-9
Screening	for	dementia	occurs	in	people	who	are	asymptomatic	
(eg,	a	certain	age,	individuals	“at	risk”).10	Case-	finding	occurs	when	
clinicians	are	 triggered	 to	explore	a	dementia	assessment	because	
of	cues	from	an	individual’s	symptoms	or	behaviour,	in	combination	
with	 pre-	existing	 knowledge	 and	 clinical	 judgement,	 but	 the	 indi-
vidual	 is	unaware	of	signs	of	dementia11	and	had	presented	to	the	
health	clinic	 for	another	 reason.	 In	contrast,	 “timely	diagnosis”	oc-
curs	when	patients	or	carers	present	to	physicians	concerned	their	
symptoms	may	be	dementia	 and	 request	 an	 assessment3 or when 
a	symptoms	adversely	affect	 the	person	or	 those	close	 to	 them.12 
Globally,	 increased	awareness	of	dementia	in	the	public	and	media	
has	 resulted	 in	many	 advocating	 for	 early	 diagnosis.1,13 There are 
two	interrelated	issues	that	arise	from	this:	first,	how	early	is	early—
at	what	time	point	should	dementia	be	identified;	and	second,	what	
approach	is	best	for	“early	identification”—screening,	case-	finding	or	
timely	diagnosis?
Recently,	 the	Royal	Australian	College	of	General	Practitioners	
(RACGP)	 updated	 their	 practice	 guidelines14 to encourage general 
practitioners	(GPs)	to	practise	“case-	finding”	for	dementia	in	people	
over	65.	The	recommendation	is	for	GPs	to	be	“alert	to	the	signs	and	
symptoms	of	dementia”	and	practise	case-	finding	by	asking	“how	is	
your	memory?”	and	obtaining	information	from	reliable	others	over	
several	appointments.	Case-	finding	can	be	considered	controversial,	
as	on	the	one	hand,	it	may	allow	for	more	timely	planning	and	iden-
tification	of	the	disease,	but	on	the	other,	it	may	also	result	in	a	po-
tentially	devastating	diagnosis	with	few	effective	treatment	options,	
turning	a	seemingly	well	person	into	a	sick	person	for	an	extended	
period	of	time.
Because	 of	 the	 fragile	 balance	 between	 potential	 harms	 and	
benefits	of	case-	finding,	we	need	to	explore	community	values	and	
preferences	 before	 case-	finding	 for	 dementia	 becomes	 an	 agreed	
practice.	We	conducted	a	citizen/community	 jury	 (CJ)	using	meth-
ods	based	on	those	described	by	the	Jefferson	Centre15	to	consider	
the	 informed	 community	 perspective	 about	 whether	 GPs	 should	
practice	 case-	finding	 for	 dementia.	 CJs	 are	 a	 form	 of	 deliberative	
democracy	used	 to	explore	community	perspectives	on	 important	
but	 controversial	 topics.15	 CJ	 participants	 are	 recruited	 from	 the	
general	population	or	the	target	population	for	the	condition	being	
studied	and	deliberate	on	questions	requiring	an	ethically	sensitive	
or	values-	based	decision.16	CJs	aim	to	elicit	an	informed community 
perspective	on	difficult	topics	where	the	values	and	preferences	of	
community	members	 enhance	 policy	 decisions.17	 CJ	members	 are	
provided	with	expert	presentations	 and	opportunities	 to	question	
the	experts,	engage	in	both	facilitated	and	private	deliberation,	and	
are	asked	to	form	a	consensus	or	majority	“verdict”	on	the	topic	ques-
tion.15	CJs	have	been	used	successfully	in	research	to	elicit	informed	
perspectives	for	several	health	policy	issues,	for	example	screening	
mammography,18,19	 screening	 for	 prostate	 cancer,20	 quantifying	
health	preferences21	and	more	broadly	in	local	governments.22,23
Our	primary	outcome	was	community	juror	recommendation	for	
the	question,	“Should	the	health	system	encourage	GPs	to	practice	
“case-	finding”	of	dementia	in	people	older	than	50?”	We	deliberately	
lowered	the	age	range	from	the	guidelines	to	over	50	years	to	reflect	
both	Australian	public	experiences	of	other	health	practices	such	as	
cancer	screening	programmes	(eg,	government	sponsored	bowel	and	
breast	cancer	screening	commence	at	age	50	in	Australia),	and	bone	
density	 checks,	 etc.	 that	 heighten	 awareness	 of	 individual	 health	
concerns,	and	to	reflect	that	younger-	onset	dementia	(although	rare)	
is	increasingly	recognized	as	a	potential	problem	confronting	practi-
tioners.24	We	also	assessed	changes	in	participant	comprehension/
knowledge	of	dementia,	attitudes	towards	dementia,	whether	they	
had	engaged	 in	an	 informed	decision,	and	explored	consistency	of	
participant’s	own	intentions	to	test	for	dementia.
2  | METHOD
2.1 | Participants
We	recruited	from	the	age	group	most	affected	by	the	question25—
50-	to	70-	year-	olds.	We	recruited	 individuals	from	the	Gold	Coast	
Region	(Australia)	with	no	(self-	reported)	previous	diagnosis	of	de-
mentia,	Alzheimer’s	disease	(AD)	or	mild	cognitive	impairment	(MCI).	
CJs	aim	to	include	participants	directly	affected	by	the	CJ	question.	
For	 this	 study,	we	deliberately	 recruited	participants	who	were	 in	
the	age	bracket	most	likely	to	be	impacted	by	GPs	case-	finding	for	
dementia	and	individuals	with	no	dementia	diagnosis.	We	excluded	
participants	with	immediate	family	members	(parents,	partners,	in-	
laws,	children	or	siblings)	diagnosed	with	dementia,	AD	or	MCI,	in-
dividuals	caring	for	someone	with	these	conditions,	and	individuals	
actively	taking	cognitive-	enhancing	medications.
Participants	 were	 recruited	 by	 the	 Social	 Research	 Centre	
(Central	Queensland	University)	using	a	randomly	selected	landline-	
based	sample	with	quotas	to	ensure	gender	and	education	balance.	
Once	recruited,	participants	were	contacted	by	the	research	team,	
provided	further	information,	asked	for	verbal	consent	and	given	de-
tails	for	their	attendance.	Participants	received	two	$100	gift	cards	
to	 reimburse	 their	 time.	 Bond	 University	 Human	 Research	 Ethics	
Committee	(#15810)	provided	ethics	approval.
2.2 | Presenting experts
We	 invited	 the	 four	 experts	 to	 present	 to	 the	 CJ	 based	 on	 their	
clinical	expertise	and	 their	publicly	 stated	positions	 towards	case-	
finding	 for	 dementia	 on	 committees,	 in	 published	 documents	 or	
both.	Each	has	clinical	or	research	experience	with	patients	with	AD	
and	dementia.	The	scientific	expert	 is	a	clinical	epidemiologist	and	
cognitive	neurologist,	and	the	ethics	expert	researches	neuroethical	
     |  3THOMAS eT Al.
issues	in	the	ageing	population.	The	expert	presenting	the	potential	
negatives	for	case-	finding	for	dementia	works	in	geriatric	medicine	
with	expertise	in	ageing	and	AD.	The	expert	presenting	the	potential	
benefits	of	case-	finding	for	dementia	is	a	GP	with	expensive	experi-
ence	working	with	patients	with	dementia	and	chaired	the	RACGP	
practice	guidelines	on	dementia.	All	experts	had	access	to	each	oth-
er’s	presentation.	Presenters,	their	topics	and	access	to	their	presen-
tations	via	URLs	are	provided	in	Box	1.	After	completion	of	the	CJ,	
expert	presenters	contributed	to	the	writing	of	the	manuscript	and	
are	named	as	co-	authors.	No	reimbursement	(financial	or	otherwise)	
was	provided	to	the	experts.
2.3 | Materials provided to CJ participants
Participants	 were	 provided	 with	 biographies	 of	 the	 experts,	 the	
schedule	of	the	weekend,	and	during	private	deliberations,	a	copy	of	
the	relevant	section	of	the	RACGP	Redbook	practice	guidelines	for	
case-	finding	of	dementia.14	In	addition,	a	printout	of	the	definitions	
used	 in	 the	 CJ	 for	 screening,	 case-	finding	 and	 diagnosis	was	 also	
provided.	The	definition	for	case-	finding	used	in	the	CJ	was	“Case-
finding—a	patient	may	 incidentally	complain	about	a	problem	(ie,	 it	
is	 not	 the	 presenting	 problem)	 that	 triggers	 suspicion	 on	 the	GPs	
behalf	and	so	is	tested	for	dementia	(eg,	complains	of	losing	words	
three	times	this	week,	forgetting	keys	etc.).”	These	patients	are	una-
ware	this	incidental	disclosure	may	indicate	signs	of	dementia.	See	
Appendix	S1	for	all	definitions.
2.4 | Patient and public involvement
We	did	not	involve	patients	in	the	design	or	recruitment	of	this	CJ.	
However,	 the	 content	 and	 structure	of	 the	CJ	were	designed	 and	
implemented	 by	 considering	 the	 feedback	 and	 suggestions	 from	
community	jurors	who	participated	in	previous	juries	this	team	had	
conducted.	Community	jurors	for	the	present	CJ	are	acknowledged	
and	thanked	in	the	acknowledgement	section	collectively,	as	identi-
fying	them	individually	by	name	would	risk	compromising	their	ano-
nymity.	CJ	participants	were	asked	whether	they	were	interested	in	
receiving	the	publication	detailing	the	results	of	the	CJ,	and	those	
who	explicitly	consented	will	be	provided	with	the	published	version	
of	the	article.
2.5 | Procedure
The	CJ	was	conducted	over	two	weekend	days,	18-	19	March	2017,	
at	Bond	University	(see	Table	1	for	schedule).	All	sessions	except	for	
the	 final	deliberation	were	 facilitated	by	a	 research	 team	member	
RT	 (a	psychologist)	 to	ensure	equal	participation,	 record	questions	
and	note	participant	concerns.	Throughout	the	2	days,	except	dur-
ing	the	final	confidential	deliberation,	two	observers	(RS	and	AMS)	
took	contemporaneous	notes	on	participant	comments,	affect	and	
participation	to	support	the	facilitator.	So	as	not	to	lead	or	bias	the	
jurors	towards	a	specific	recommendation,	no	one	outside	of	the	jury	
group	was	present	during	private	deliberations.
On	Saturday,	participants	provided	written	consent	and	completed	
the	pre-	CJ	(baseline)	survey.	Experts	with	clinical	and	research	ex-
pertise	in	the	areas	of	cognitive	impairment	and	dementia,	geriatric	
medicine,	 epidemiology	 and	 ethics	 spoke	 about	 specific	 informa-
tion	about	dementia,	ethical	considerations	regarding	case-	finding,	
and	the	perceived	benefits	and	harms	of	case-	finding	for	dementia	
in	general	practice.	Each	expert	presented	a	20-	minute	voice-	over	
slide	 presentation	 (see	 Box	1	 for	 details)	 followed	 by	 a	 telephone	
question	and	answer	session.	Participants	were	provided	with	pre-
senters’	biographies	and	handouts	of	their	presentations.
On	 Sunday,	 participants	 debriefed,	 discussed	 overnight	 reflec-
tions	and	were	provided	the	opportunity	 to	recontact	 the	experts	
via	telephone	for	further	information	and	clarification.	Participants	
then	deliberated	in	private	on	the	primary	question	and	were	able	to	
ask	for	clarification	on	any	matter	during	this	time.	They	then	pre-
sented	their	decision	to	the	facilitator	and	researchers.
2.6 | Measures
It	is	important	to	ascertain	that	CJ	participants	made	an	“informed	
decision”	when	providing	their	recommendations.	This	requires	ad-
equate	comprehension	of	the	topic	and	a	consistency	between	their	
personal	attitudes	towards	the	topic	and	their	personal	intentions.26
Information	questions	are	used	in	CJs	to	assess	participant	com-
prehension	of	information	presented	to	them	by	the	experts	during	
the	CJ.	Therefore,	questions	and	answers	are	developed	 from	the	
expert	presentations	and	are	reflective	of	the	information	provided	
and	 are	 not	 meant	 to	 be	 reflective	 of	 higher	 clinical	 or	 research	
knowledge.	 Ten	 comprehension	 questions	 were	 developed	 from	
information	provided	during	the	expert	presentations	 (seven	true/
false	conceptual	 items	and	 three	multiple	choice	numerical	 items).	
Post-	CJ	 adequate	 comprehension	 was	 defined	 a	 priori	 as	 50%	
correct.27
Attitudes	 towards	 case-	finding	 for	 dementia	 were	 assessed	
using	five	items	on	a	7-	point	scale	with	the	higher	number	suggest-
ing	more	positive	attitudes.26-28	A	positive	attitude	was	defined	as	
scores	≥28/35.27
We	measured	 future	 intention	 to	undergo	case-	finding	 for	de-
mentia	 if	 suggested	 by	 a	GP	 using	 a	 7-	point	 scale	 ranging	 from	1	
(definitely	not)	to	7	(definitely	will).	Scores	between	5-	7	were	classi-
fied	as	positive	intentions,	and	scores	between	1-	3	and	4	(unsure)	as	
Box 1 Expert presentations and download links
1.	What	 is	 dementia,	 how	 is	 it	 diagnosed,	 and	 what	 are	 the	
treatment	options
(Clement	Loy)	https://youtu.be/ssFmga7p39Q
2.	The	ethics	of	case-finding	for	dementia
(Cynthia	Forlini)	https://youtu.be/iz-3hWiw5Jw
3.	The	potential	harms	of	case-finding	for	dementia
(David	Le	Couteur)	https://youtu.be/l1tK8NFfhjw
4.	The	potential	benefits	of	case-finding	for	dementia
(Dimity	Pond)	https://youtu.be/lqgn8VHO5CI
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negative	 intentions.	To	explore	the	time	and	 information	provision	
required	for	an	individual	to	achieve	consistent	responses,	we	asked	
participants	 this	 same	 question	 on	 nine	 occasions:	 baseline;	 after	
each	expert	presentation;	at	the	end	of	day	1;	at	the	start	of	day	2;	
after	deliberation;	and	at	the	end	of	day	2.
Informed	 choice	was	 defined	 as	 adequate	 relevant	 knowledge	
and	a	consistency	between	individual	attitudes	and	intentions.26,27 
The	post-	CJ	survey	is	available	in	the	Appendix	S1.
2.7 | Statistical analyses
The	 CJ	 proceedings	 were	 audio-	recorded	 and	 transcribed.	
Participants’	 recommendations	on	 the	primary	question	were	also	
recorded	on	a	whiteboard,	corrected	by	participants	and	participant	
notes	were	also	provided.	Transcripts	were	analysed	qualitatively	to	
identify	reasons	for	 juror	recommendations.	We	analysed	compre-
hension/knowledge,	attitudes	and	 intentions	 in	a	before	and	after	
study	design.	Paired	pre-	to	post-	CJ	differences	for	continuous	out-
comes	were	 examined	 using	Wilcoxon	 signed	 rank	 tests.	 All	 data	
were	analysed	in	SPSS	Statistics	23	(IBM	Corp.,	Armonk,	NY,	USA).
3  | RESULTS
Of	 the	 14	 participants	 recruited,	 12	were	 available	 for	 the	week-
end	and	agreed	to	participate	in	the	study.	Of	these,	one	withdrew	
prior	to	day	1	(male	aged:	60-	70	years),	and	one	did	not	attend	for	
unknown	 reasons	 (female	 aged:	 60-	70	years).	 Ten	 participants	 at-
tended	and	completed	the	CJ.	The	average	age	of	participants	was	
62	years	(SD	=	6.9;	median	62.5	years,	IQR	=	12.25),	and	there	was	
an	even	gender	split.	Education	levels	were	mixed.	Nine	participants	
indicated	they	had	not	been	tested	for	dementia	and	one	was	unsure	
(Table	2).
3.1 | Community jury recommendation
Community	 jury	 participants	 engaged	with	 each	 presentation	 and	
asked	 questions	 of	 each	 presenter	 immediately	 following	 their	
presentation.	On	the	morning	of	day	2,	CJ	participants	also	asked	
further	clarifying	questions	to	speakers	1,	3	and	4	(See	Table	1	for	
speaker	details).	After	the	deliberations	on	day	2,	participants	voted	
Saturday
9.00-	9.30 Overview	of	community	jury Rae	Thomas
9.30-	10.00 What	is	dementia,	how	is	it	
diagnosed	what	are	the	treatment	
options
Clement	Loy
10.00-	10.30 Questions
10.30-	11	am MORNING	TEA
11.00-	11.30 The	ethics	of	case	finding	for	
dementia
Cynthia	Forlini
11.30-	12.00 Questions
12.00-	12.30 LUNCH
12.30-	1.00 The	potential	harms	of	case	finding	
for	dementia
David	Le	Couteur
1.00-	1.30 Questions
1.30-	2.00 The	potential	benefits	of	case	
finding	for	dementia
Dimity Pond
2.00-	2.30 Questions
Flexible	timing	in	
response	to	Juror	
needs
Jury	deliberations	Stage	1 Rae	Thomas
AFTERNOON	TEA
Questions	and	Close
Sunday
9.00-	9.30 Reconnect	and	Debrief Rae	Thomas
9.30-	10.30 Further	questions	and	
deliberations
Rae	Thomas	(or	private	if	
jurors	ready)
Flexible	timing	in	
response	to	Juror	
needs
MORNING	TEA
Deliberations	until	consensus	or	
impasse
LUNCH
Deliver	Verdict
Debrief,	Process	discussion	and	
close
TA B L E  1  Community	jury	schedule
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unanimously	(10/10)	against	the	jury	charge:	“Should	the	health	sys-
tem	encourage	GPs	to	practice	case-	finding	of	dementia	 in	people	
older	 than	 50?”	 Reasons	 included	 the	 following:	 lack	 of	 effective	
treatments	for	dementia	(ie,	cure),	case-	finding	may	occur	too	early	
in	the	course	of	the	disease,	the	impact	case-	finding	might	have	on	
an	 individual’s	mental	health,	 the	 role	of	 the	GP	and	 the	potential	
financial	 incentives	 for	 case-	finding	 (Box	2).	 The	 wording	 of	 the	
charge	challenged	the	participants.	They	believed	the	age	of	case-	
finding	in	the	charge	at	50	years	was	“too	young”	(J2)	and	thought	
the	word	“encourage”	might	translate	to	financial	incentives.
Despite	 a	 unanimous	 “no”	 verdict,	 participants	 recognized	 that	
because	 guidelines	 for	 case-	finding	 of	 dementia	 were	 outlined	 in	
the	RACGP	Clinical	Guidelines	 for	Preventive	Activities	 in	General	
Practice,	 GPs	 were	 currently	 practicing	 case-	finding	 for	 dementia.	
Participants	 requested	 and	were	 given	 a	 copy	of	 the	 relevant	 sec-
tion	in	the	RACGP	Clinical	Guidelines	and	they	made	alterations	they	
considered	would	“stop	it	[case-	finding	for	dementia]	from	happen-
ing	 in	 a	 harmful	 way”	 (J7).	 (J7	 was	 nominated	 by	 the	 participants	
pre-	deliberation	as	the	fore-	person	and	spokesperson.)	J7	“So	given	
that	 it’s	here	to	stay,	we’d	 like	to	adjust	these	[RACGP]	guidelines.”	
Importantly,	 despite	 the	 current	 guidelines	 suggesting	 case-	finding	
occur	in	people	over	65,	and	participants	believing	the	age	of	50	in	
the	jury	“charge”	was	too	young,	the	jurors	recommended	removing	
the	age	criterion	from	the	guidelines.	They	reasoned	that	as	demen-
tia	did	occur	in	younger	ages	(although	rare),	by	removing	age	cave-
ats	“all	individuals	would	have	equal	access	and	equitable	treatment	
regardless	 of	 age.”	 The	 participants’	 recommended	 changes	 to	 the	
section	referencing	case-finding	for	dementia	in	the	RACGP	Clinical	
Guidelines	are	provided	without	edit	in	the	Appendix	S1.
In	addition,	 to	specific	guideline	changes,	 the	participants	sug-
gested	 potential	 solutions	 (Box	3).	 For	 example,	 although	 the	 par-
ticipants	thought	they	knew	about	dementia	from	media	and	public	
discourse,	they	were	surprised	to	learn	that	there	are	currently	no	
effective	 treatments	 and	 that	 prevention	 rests	 upon	 modifiable	
risk	factors	that	may	decrease	risk	of	dementia	but	not	eliminate	it.	
Therefore,	participants	believed	the	public	were	not	fully	cognisant	
of	information	about	dementia	required	to	make	an	informed	health	
decision.	Participants	recommended	a	public	awareness	campaign.	
Finally,	in	response	to	concerns	about	financial	incentives	for	case-	
finding	for	dementia,	the	participants	suggested	that	any	potential	
incentives	be	invested	into	research	to	address	prevention	and	man-
agement	of	dementia.
3.2 | Comprehension, attitudes and intention to test
At	 pre-	CJ,	 participant	 comprehension/knowledge	 about	 dementia	
was	good	with	eight	participants	scoring	6	or	7/10	correct	and	two	
participants	 scoring	 4/10	 correct.	 Overall,	 comprehension	 scores	
significantly	increased	from	pre-	to	post-	CJ	(median:	6,	IQR:	6-	6	vs	
median:	7,	IQR:	7-	8,	P	=	0.004;	Table	3).	At	post-	CJ,	all	participants	
had	 adequate	 comprehension	 based	 on	 presentation	 information	
with	nine	participants	achieving	7	or	8/10	correct	and	one	partici-
pant	scoring	5/10.
Before	 the	CJ,	participants’	 attitudes	 towards	case-	finding	 for	de-
mentia	were	mixed	with	four	participants	reporting	an	overall	nega-
tive	(score	of	<28)	and	five	participants	an	overall	positive	attitude	
(≥28,	median	=	30,	IQR	=	22-	34).	Data	were	missing	for	one	partici-
pant.	However,	after	the	CJ,	participants	reported	significantly	less	
favourable	attitudes	with	only	two	participants	maintaining	overall	
positive	 attitudes	 towards	 case-	finding	 (median	=	12,	 IQR	=	6-	20,	
P = 0.01).
Pre-	CJ,	 most	 participants	 reported	 positive	 intentions	 to	 un-
dergo	 case-	finding	 for	 dementia	 should	 it	 be	 suggested	 (8/10;	
Figure	1).	 However,	 only	 three	 participants	 thought	 this	 post-	CJ.	
This	was	a	statistically	significant	decline	in	the	overall	intention	to	
test	score	(median	=	7,	IQR	=	6-	7,	vs	median	=	2,	IQR	=	1-	6,	P = 0.01).
3.3 | Informed decision
Using	 the	 algorithm	 for	 informed	 decision	making	 (≥50%	 compre-
hension	 questions	 correct	 and	 congruence	 between	 attitude	 and	
intentions	 to	 test),	 nine	 participants	 made	 an	 informed	 decision	
post-	CJ.	The	remaining	participant	scored	negatively	on	their	atti-
tude	towards	case-	finding	(score	of	20)	but	indicated	they	“definitely	
will”	(score	of	7)	undergo	case-	finding	for	dementia	if	offered.
3.4 | Consistency in decision making
Seven	 participants	 decreased	 their	 individual	 intentions	 to	 un-
dergo	 case-	finding	after	 the	 first	 expert	presentation.	After	 this	
change,	most	 (6/10)	maintained	 their	 individual	 intentions	 (posi-
tive,	negative	or	unsure)	to	test	for	dementia	after	either	the	scien-
tific	or	ethics	presentations	(Figure	1).	Two	participants	continued	
to	decrease	 their	 intentions	 to	 test	until	 the	 start	of	 the	 second	
day	after	which	they	remained	consistent.	Two	other	participants	
changed	their	individual	intentions	up	until	the	end	of	the	assess-
ment period.
TA B L E  2  Participant	demographics	(N	=	10)
Age
Mean	(SD) 62	(6.9)
Median	(IQR) 62.5	(12.25)
Male	(n)/female	(n) 5/5
Previous	MCI/dementia	test	(n)
Yes 0
No 9
Don’t	know 1
Education	(n)
Some	high	school 3
Grade	12 4
Some	university/TAFE 2
University	postgraduate 1
MCI,	mild	cognitive	impairment;	TAFE,	technical	and	further	education	
institutions.
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4  | DISCUSSION
Our	 informed	community	members	did	not	believe	Australian	GPs	
should	practice	case-	finding	for	dementia.	Their	reasonings	included	
the	 futility	of	being	diagnosed	 in	 the	absence	of	 symptoms	of	 im-
pairment	when	there	was	little	evidence	of	effective	prevention	or	
treatment	strategies	and	that	case-	finding	(compared	with	timely	di-
agnosis)	had	the	potential	to	evoke	unnecessary	worry.	In	addition,	
after	the	CJ,	participants	on	average	increased	their	comprehension	
of	dementia	(according	to	information	presented	to	them),	decreased	
their	positive	attitudes	towards	case-	finding	and	their	own	intention	
to	 undergo	 case-	finding	 for	 dementia	 should	 it	 be	 suggested,	 and	
made	an	informed	decision	regarding	the	CJ	question.
Research	 supports	 their	 position.	 A	 recent	 systematic	 review	
on	the	benefits	and	challenges	of	timely	diagnosis	of	AD3 reported 
that	 some	 challenges/harms	 faced	 by	 potential	 patients	 included	
fear,	anxiety,	worry	and	stigma.	Unlike	our	definition	of	case-	finding,	
these	 reported	challenges	were	within	 the	 context	of	people	pre-
senting	specifically	with	concerns	about	their	cognitions.	In	another	
study,	 individuals	 diagnosed	 with	 MCI	 compared	 with	 individuals	
with	normal	cognitive	functioning	reported	a	reduced	quality	of	life,	
significantly	 more	 depression	 and	 stress.6	 Additionally,	 the	 same	
study	reported	that	individuals	unaware	of	their	diagnosis	of	either	
MCI	or	AD	reported	greater	quality	of	life	and	better	well-	being	than	
those	aware	of	the	diagnosis,6	suggesting	that	regardless	of	symp-
toms,	the	diagnostic	label	itself	was	harmful	to	some.
Box 2 Justifications for jury decision
No effective treatment
Juror	5:	I	think	that	until	there	is	a	definite	chance	of	stopping	or	fixing	the	problem,	it	would	create	a	far	greater	negative	outcome	than	
a	positive	one.
Juror	1:	It	was	a	surprise	to	me	that	I	didn’t	realise	there	was	actually	nothing	that	could	be	done	to	help	anybody	with	it.
Case- finding too early in the course of the disease
Juror	5:	You	know,	we’re	getting	told	very	early	when	it’s	going	to	be	10	years	before	it	appears,	that	would	be	10—for	a	lot	of	people,	that	
would	be	10	years	of	worry.
Juror	6:	I	look	at	it	this	way,	that	the	diagnosis	stage	is	still	early	enough	for	planning.
Role of the GP
Juror	1:	GPs	overstepping	role	“Unless	the	patient	specifically	has	a	concern	that	they	speak	to	their	GP	about,	then	I	don’t	think	the	GP	
should	step	in.	I	think	it’s	for	testing,	screening,	whatever,	that	is	something	that	is	entirely	up	to	the	patient.”
Juror	1:	I	just	think,	what	gives	a	GP	a	right	to	play	god?
Juror	2:	When	somebody	mentions	dementia	or	Alzheimer’s	to	somebody,	you	are	placing	fear	into	their	mind….I	don’t	think	it	is	the	doc-
tor’s	right	to	set	somebody	up	with	that	fear.
Mental health
Juror	10:	I	see	that	to	be	diagnosed	and	told	that	you	are	destined	to	become	a	person	with	dementia,	will	be	devastating	for	anyone.	For	
those	patients	who	are	misdiagnosed	and	caused	unnecessary	fear	and	indignity,	it	would	be	far	worse.
Juror	5:	I	was	involved	a	lot	in	the	AIDS	thing	way	back	and	there	were	people	hearing	they	had	it	and	going	out	and	killing	themselves,	
like	that,	you	know,	just	the	shock.	So	the	same	thing	could	apply	with	this.	It’s	a	death	sentence	in	a	way.
Juror	2:	The	stress	and	anxiety	of	people	that	might	get	diagnosed	or	misdiagnosed	just	outweighs	the	positives	that	might	be.
Juror	1:	They	just	don’t	know	what	effect	mentally	that’s	going	to	have	on	that	person.
Potential incentivisation
Juror	2:	…encouraging	GPs	would	just	encourage	kickbacks	and	overdiagnosis	because	people,	like	people	are,	they	want	to	profit.
Juror	4:	I	had	a	doctor	telling	me	once	about	try	these	things	and	telling	me	about	the	holiday	he	had	because	of	the	incentive.
Less frequently expressed concerns
Juror	6:	Has	any	one	of	us	considered	the	cost	factor	on	the	whole	community?	Because	all	the	screening	and	referrals	to	specialists	and	
counsellors	and	-	it	must	be	huge	and	basically	for	nothing.
Juror	2:	Your	medical	insurance	would	dump	you	like	a	brick.
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Despite	 their	 opposition,	 the	 community	members	 recognized	
case-	finding	 was	 promoted	 in	 the	 RACGP	 Clinical	 Guidelines	 for	
people	over	65	years.14	So,	CJ	participants	suggested	changes	to	the	
guidelines	including	wide-	scale	public	education	regarding	diagnos-
tic,	prognostic	and	treatment	uncertainty;	clinician	education	on	dis-
cussing	this	uncertainty;	and	concerns	about	any	potential	financial	
incentives	by	explicitly	prohibiting	these,	and	instead	redirecting	any	
monies	 towards	 preventive	 and	 treatment	 research.	 Despite	 con-
cern	regarding	the	low	age	of	case-	finding	posed	in	our	CJ	question,	
participants	 suggested	 eliminating	 the	 age	 criterion	 to	 reflect	 the	
rare	but	important	possibility	of	early	age	onset.
The	study	has	several	strengths.	This	was	the	first	CJ	we	are	aware	
of	to	explore	community	values	and	preferences	of	case-	finding	for	
dementia.	CJs	provide	participants	with	expert	information	and	the	
ability	to	question	the	experts,	thus	capturing	participants’	informed 
views	and	preferences.	This	contrasts	with	other	forums	that	garner	
public	opinion	which	 lack	 the	 information	provision	element,	 such	
as	focus	groups	and	population	surveys.	For	example,	public	views	
on	 screening	 for	 prostate	 cancer	 are	 generally	 positive.	When	we	
conducted	a	CJ	on	this	topic,	pre-	CJ	screening	intentions	and	atti-
tudes	were	positive	(as	would	be	expected)20;	however,	post-	CJ	this	
position	was	reversed.	As	is	usual	practice,	in	this	CJ	we	selected	our	
participants	following	CJ	practices	of	randomly	recruiting	from	the	
“affected	public.”16	As	CJs	 recruit	participants	who	are	potentially	
affected	by	the	question16	 (case-	finding),	we	deliberately	excluded	
carers	 and	 individuals	 diagnosed	with	MCI	 or	 dementia.	 Our	 par-
ticipants	 therefore	 represent	 the	 authentic	 experiences	of	 service	
users	with	no	vested	 interest	 in	 the	 topic.16	We	acknowledge	 the	
jury	decision	may	have	been	different	should	other	members	of	the	
public	have	been	included.	For	example,	previous	research	reported	
that	 92%	 of	 individuals	 attending	 a	memory	 clinic	 to	 assess	 their	
cognitive	functioning	wanted	to	know	the	outcome	of	their	assess-
ment.29	However,	these	people	had	already	consented	to	testing	so	
were	unlike	participants	affected	by	our	question.	Although	review	
papers	report	“most	people	want	to	know,”30	participants	in	this	CJ	
(the	affected	public	for	case-	finding)	were	mixed	in	their	individual	
intentions	to	undergo	testing	yet	unanimously	against	 its	common	
practice.	Participant	comments	suggest	broad	public	awareness	of	
dementia	but	a	more	limited	understanding	of	issues	related	to	prog-
nosis	and	treatment.	Finally,	to	aid	reproduction	and	transparency,	
the	reporting	of	the	CJ	complies	with	the	CJCheck	reporting	proto-
col31	and	all	presentations	are	available	for	viewing.
However,	 there	are	also	 limitations.	 Lowering	 the	age	 range	 in	
the	RACGP	guidelines	 from	65	to	50	years,	which	 reflects	current	
diagnostic	 concerns	 of	 younger-	onset	 dementia24	 and	 aligns	 with	
other	 screening	 health	 practices	 in	 Australia,	 may	 be	 a	 limitation	
because	 it	 does	 not	 reflect	 current	 guideline	 recommendations.	
However,	although	the	jurors	initially	thought	this	age	“too	young”	
their	final	recommendations	to	the	RACGP	included	eliminating	the	
age	criterion	altogether.	Their	 justification	 for	doing	so	was	 to	ac-
knowledge	the	rare	occasions	of	younger-	onset	dementia	and	to	in-
crease	“equal	access	and	equitable	treatment	regardless	of	age.”	This	
is	 an	example	of	where	 community	 juror	 recommendations	would	
need	 to	be	viewed	by	epidemiologists	before	potential	 implemen-
tation.	Removing	age	criterion	for	case-	finding	for	dementia	would	
significantly	 lower	 the	 positive	 predictive	 value	 of	 diagnosis	 rates	
because	the	prevalence	of	dementia	in	young	age	groups	is	very	low.
By	 design,	 CJs	 are	 small18-21	 and	 this	 is	 often	 a	 criticism.	 CJ	
participants	 are	 not	 suggested	 to	 represent	 the	 larger	 popula-
tion.	 They	 should	 be	 selected	 randomly	with	 quotas	 of	 important	
Box 3 Potential solutions suggested by Jurors
Public awareness
Juror	8:	there	needs	to	be	more	education	so	people	can	sort	of	
make	an	informed	choice	of	whether	they	want	to	go	and	talk	to	
their	GP	about	it.
Juror	 7:	 we’d	 like	 to	 add	 in	 education	 and	 awareness	 pro-
grams……	 [about]	 dementia,	 the	 signs,	 the	 symptoms	 and	 the	
processes	and	treatments	and	supportive	systems…
Juror	5:	also	lifestyle	education…
Juror	7:	at	an	early	age.
Reallocation of any potential incentives
Juror	2:	Wouldn’t	it	be	nice,	if	the	government,	instead	of	giving	
kickbacks	to	doctors	or	pharmaceutical	companies	…….	if	they	
all	[the	government]	put	their	money	in	more	research	to	cure	
the	damn	thing	in	the	first	place?
Juror	6:	I	think	it	would	be	good	if	legislation,	government	legis-
lation	was	passed	that	all	incentives,	from	wherever	they	come,	
should	be	diverted	from	the	doctor	to	a	research	facility.
Juror	7:	………	because	research	funding	is	so	scarce,	any	incen-
tive	a	doctor	is	given	to	refer	to	a	memory	clinic	to	any	other	
centre,	 that	 incentive	does	not	go	 into	 the	doctor’s	pocket,	 it	
goes	into	a	funding	body	for	research	into	dementia.
TA B L E  3  Differences	in	comprehension/knowledge,	attitudes	and	intentions	pre-	to	post-	community	jury
N
Pre- CJ Post- CJ
Wilcoxon P- valueMedian Q1 Q3 Median Q1 Q3
Comprehension/knowledge	
total	(/10)
10 6 6 6 7 7 8 0.004
Attitudes	total	(/35) 9 30 22 34 12 6 20 0.01
Intention	to	test	(/7) 10 7 6 7 2 1 6 0.01
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characteristics	relevant	to	the	topic	(eg,	gender,	age	range).	If	this	CJ	
was	repeated	with	different	participants,	with	different	values	and	
preferences,	the	recommendations	may	differ	from	those	described	
here.	Outcomes	of	CJs	may	not	be	able	to	be	replicated	but	methods	
are	 reproducible.	 Recently,	 two	 CJs	 on	 antimicrobial	 stewardship	
were	 conducted	 in	 different	 settings	with	 similar	 results	 suggest-
ing	 once	 informed,	 participants	 (in	 different	 regions	 but	 recruited	
for	characteristics	relevant	to	the	juror	question)	may	make	similar	
recommendations.32	 Also,	 careful	 consideration	 is	 taken	 to	 select	
experts	with	known	clinical	and	research	expertise	and	with	differ-
ences	of	opinion	(for	and	against	case-	finding).	They	had	access	to	
each	other’s	presentations	for	transparency	and	potential	comments	
and	 research	 presented	 to	 support	 their	 claims	 were	 referenced.	
However,	CJ	participants	can	only	be	“informed”	from	the	informa-
tion	 provided	 by	 these	 experts.	 If	 different	 experts	 had	 been	 se-
lected,	different	information	may	have	been	provided.	CJs	are	only	
used	for	controversial	topics;	in	this	arena	universal	truths	are	rare.
It	is	not	suggested	that	Australian	GP	guidelines	change	because	of	
the	CJ	recommendations;	indeed,	the	recommendation	to	remove	the	
age	requirement	would	require	considerations	of	the	sensitivity	and	
specificity	of	any	tests	with	a	different	age	cut-	off	which	 is	beyond	
the	information	provided	to	the	jurors.	But	this	study	does	highlight	
some	important	implications	for	guideline	developers	and	clinicians.
Research	has	demonstrated	guideline	development	groups	and	
panels	that	decide	new	definitions	of	disease	or	diagnostic	practices	
often	comprise	panel	members	with	 financial	 ties	 to	pharmaceuti-
cal	 companies,	 and/or	emotional	 and	academic	vested	 interests.33 
Missing	from	these	groups	are	community	voices,	values	and	pref-
erences.	 CJs	 provide	 a	 mechanism	 to	 elicit	 informed	 community	
values	and	preferences	which	can	help	 inform	guideline	and	panel	
groups.	For	 clinicians,	 the	assumption	 that	most	 individuals	would	
want	 to	 know	 about	 a	 diagnosis	 of	 dementia,	 when	made	 before	
symptoms	are	known	to	the	patient,	is	contestable.	When	informed	
about	the	potential	harms	and	benefits	of	case-	finding	for	dementia,	
community	members	were	unanimously	against	a	universal	service	
and	mixed	 in	 their	 individual	health-	care	decisions.	Australian	GPs	
should	carefully	consider	case-	finding	for	dementia	in	their	practice	
given	the	lack	of	effective	treatments	and	the	potential	to	add	years	
of	stress	and	uncertainty	to	patients’	lives.	Shared	decision	making34 
is	essential	when	views	are	so	mixed.
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